Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)

Real-time Quote. Real-time Tradegate - 09/28 10:36:25 am
70.41 EUR   +0.03%
09/26 UCB : and Amgen announce U.S. FDA acceptance of biologics licence ap..
09/26 UCB : Transparency notification
09/19 UCB : receives positive EU CHMP opinion for CIMZIA® (certolizumab pe..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
09/22/2016 09/23/2016 09/26/2016 09/27/2016 09/28/2016 Date
72.24(c) 71.84(c) 70.26(c) 70.39(c) 70.49 Last
267 936 227 773 248 208 193 651 22 331 Volume
-0.52% -0.55% -2.20% +0.19% +0.14% Change
More quotes
Financials (€)
Sales 2016 4 046 M
EBIT 2016 743 M
Net income 2016 456 M
Debt 2016 1 001 M
Yield 2016 1,79%
Sales 2017 4 321 M
EBIT 2017 898 M
Net income 2017 548 M
Debt 2017 653 M
Yield 2017 1,88%
P/E ratio 2016 27,09
P/E ratio 2017 22,17
EV / Sales2016 3,63x
EV / Sales2017 3,32x
Capitalization 13 691 M
More Financials
Company
UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products.It offers medicinal products for central nervous system and immunology disorders under the Cimzia, Xyzal, Zyrtec, Tussionex, Lortab, Vimpat, Keppra and Neupro.The company was founded by... 
Sector
Pharmaceuticals
Calendar
10/25Earnings Release
More about the company
Surperformance© ratings of UCB
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB
09/26 UCB : and Amgen announce U.S. FDA acceptance of biologics licence application fo..
09/26 UCB : Transparency notification
09/19 UCB : receives positive EU CHMP opinion for CIMZIA® (certolizumab pegol) AutoCli..
09/18 UCB : Results from phase 3 Frame study of romosozumab showed significant reducti..
09/16 UCB : Transparency notification
09/08 UCB : Transparency notifications
08/29 DAIICHI SANKYO : Antiepileptic lacosamide filed for partial amendment of approva..
08/19 UCB : Transparency notification
08/18 UCB : Transparency notification
08/14 UCB : U.S. District Court confirms validity of patent for UCB's Vimpat®
More news
Sector news : Pharmaceuticals - NEC
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
09/26 MYLAN : faces scrutiny over EpiPen profit data shown to Congress
09/26DJPFIZER : Throws Out Plan to Split Into Two Companies -- 2nd Update
09/26DJPfizer Throws Out Plan to Split Into Two Companies
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/31 UCB S.A. 2016 Q1 - Results - Earnings Call Slides
07/31 UCB's (UCBJF) CEO Jean-Christophe Tellier on Q2 2016 Results - Earnings Call ..
07/22 Amgen submits BLA in U.S. for osteoporosis candidate romosozumab
05/28 LANNETT : Structural Benefits Of The Kremers Acquisition: 100+% Upside
03/21 Amgen's romosozumab successful in late-stage study in men with osteoporosis
Advertisement
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Technical analysis trends UCB
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 79,0 €
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jean-Christophe Tellier Chief Executive Officer & Executive Director
Gerhard N. Mayr Chairman
Mark D. McDade Chief Operating Officer & Executive Vice President
Detlef Thielgen Chief Financial Officer & Executive Vice President
Iris Loew-Friedrich Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
UCB-15.43%15 367
JOHNSON & JOHNSON16.06%322 232
ROCHE HOLDING LTD.-12.41%215 081
NOVARTIS AG-10.14%211 231
PFIZER INC.4.80%204 049
MERCK & CO., INC.18.46%171 858
More Results